Delphia (Usa) Inc. Recursion Pharmaceuticals, Inc. Transaction History

Delphia (Usa) Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $74,136 - $161,604	-16,258 Reduced 61.42%	10,212 $76,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $169,937 - $255,170	26,470 New	26,470 $176,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $92,136 - $169,282	18,281 New	18,281 $149,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.41B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.